What is the ticker symbol for Silexion Therapeutics?

Silexion Therapeutics trades under the ticker SLXN on NASDAQ.

What sector does Silexion Therapeutics operate in?

Silexion Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SLXN in a portfolio?

PortView shows SLXN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Silexion Therapeutics (SLXN) Stock Analysis

NASDAQHealthcareBiotechnology

$0.37+0.68%

1-year price historyRange $0.35 – $71.50

52-week range$0.37

$0.35$77.70

What Silexion Therapeutics does

Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: SiG12D-LODER, which has progressed through both preclinical studies and an open-label Phase I clinical trial for pancreatic cancer; Prostate-LODER, currently undergoing preclinical evaluation for prostate cancer; and GBM-LODER, also in preclinical development, targeting Glioblastoma Multiforme, a highly malignant primary brain tumor. Founded in 2008, Silexion Therapeutics is headquartered in Jerusalem, Israel.

Key metrics

Market cap

$156,118

P/E (TTM)

-0.01

EPS (TTM)

$-39.55

Beta

-0.25

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.76

200-day avg

$11.84

52-week high

$77.70

52-week low

$0.35

CEO

Ilan Hadar

ETFs linked to SLXN

Broad-market and Healthcare sector ETFs an investor holding Silexion Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SLXN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SLXN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Silexion Therapeutics?: Silexion Therapeutics trades under the ticker SLXN on NASDAQ.
Which exchange is SLXN listed on?: SLXN is listed on NASDAQ.
What sector does Silexion Therapeutics operate in?: Silexion Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SLXN in a portfolio?: PortView shows SLXN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.